Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023

作者：Zian Lin, Xue Liang, Lixian Su, Weijun Peng, Hongbiao Chen, Yuan Fang, Siyu Chen, Weikang Yang, Wensheng Chen, Lijun Zhang, Zixin Wang · 发表于：Vaccines · 年份：2024 · DOI：10.3390/vaccines12010075 · 被引用次数：14 · 研究领域：Cervical Cancer and HPV Research、Genital Health and Disease、Hepatitis B Virus Studies

China started to offer human papillomavirus (HPV) vaccines to females aged 9-45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to examine the current HPV coverage and associated factors among females aged 9-50 years in Shenzhen, China, based on administrative health records kept by community health centers. A multistage random sampling approach was used. The research team randomly selected 18 community health centers in Shenzhen, and 3118 health records of females aged 9-50 years were then randomly selected from these health centers. Among all participants, 18.7% received at least one dose of HPV vaccination. The highest coverage was observed among females aged 18-26 years (23.4%), followed by those aged 27-35 years (22.0%) and 36-45 years (20.2%). Such coverage was very low among females aged 9-17 years (4.6%) and those aged 46-50 years (3.2%). Among females aged 18 years or above, higher education level, having a family doctor, and permanent residency in Shenzhen were associated with higher HPV vaccination coverage, while older age and being married/divorced were negatively associated with coverage. The HPV vaccination coverage in Shenzhen was 18.7% and there is a strong need for improvement.